Prioritizing Cancer lncRNA Modulators via Integrated lncRNA-mRNA Network and Somatic Mutation Data

Page: [723 - 734] Pages: 12

  • * (Excluding Mailing and Handling)

Abstract

Background: Long noncoding RNAs (LncRNAs) represent a large category of functional RNA molecules that play a significant role in human cancers. lncRNAs can be gene modulators to affect the biological process of multiple cancers.

Methods: Here, we developed a computational framework that uses the lncRNA-mRNA network and mutations in individual genes of 9 cancers from TCGA to prioritize cancer lncRNA modulators. Our method screened risky cancer lncRNA regulators based on integrated multiple lncRNA functional networks and 3 calculation methods.

Results: Validation analyses revealed that our method was more effective than prioritization based on a single lncRNA network. This method showed high predictive performance, and the highest ROC score was 0.836 in breast cancer. It’s worth noting that we found that 5 lncRNAs scores were abnormally high, and these lncRNAs appeared in 9 cancers. By consulting the literature, these 5 lncRNAs were experimentally supported lncRNAs. Analyses of prioritizing lncRNAs reveal that these lncRNAs are enriched in various cancer-related biological processes and pathways.

Conclusion: Together, these results demonstrated the ability of this method to identify candidate lncRNA molecules and improved insights into the pathogenesis of cancer.

Keywords: computational framework, lncRNA-mRNA network, mutations, cancer lncRNA modulators

Graphical Abstract

[1]
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020; 70(1): 7-30.
[http://dx.doi.org/10.3322/caac.21590] [PMID: 31912902]
[2]
Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144(5): 646-74.
[http://dx.doi.org/10.1016/j.cell.2011.02.013] [PMID: 21376230]
[3]
Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science 2013; 339(6127): 1546-58.
[http://dx.doi.org/10.1126/science.1235122] [PMID: 23539594]
[4]
Weinstein JN, Collisson EA, Mills GB, et al. The cancer genome atlas pan-cancer analysis project. Nat Genet 2013; 45(10): 1113-20.
[http://dx.doi.org/10.1038/ng.2764] [PMID: 24071849]
[5]
Cheng F, Zhao J, Zhao Z. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes. Brief Bioinform 2016; 17(4): 642-56.
[http://dx.doi.org/10.1093/bib/bbv068] [PMID: 26307061]
[6]
Gutschner T, Hämmerle M, Eissmann M, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 2013; 73(3): 1180-9.
[http://dx.doi.org/10.1158/0008-5472.CAN-12-2850] [PMID: 23243023]
[7]
Niu Y, Ma F, Huang W, et al. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2. Mol Cancer 2017; 16(1): 5.
[http://dx.doi.org/10.1186/s12943-016-0575-6] [PMID: 28069000]
[8]
Chakravarty D, Sboner A, Nair SS, et al. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat Commun 2014; 5: 5383.
[http://dx.doi.org/10.1038/ncomms6383] [PMID: 25415230]
[9]
Guo X, Gao L, Liao Q, et al. Long non-coding RNAs function annotation: A global prediction method based on bi-colored networks. Nucleic Acids Res 2013; 41(2)e35
[http://dx.doi.org/10.1093/nar/gks967] [PMID: 23132350]
[10]
Li J, Han L, Roebuck P, et al. TANRIC: An interactive open platform to explore the function of lncrnas in cancer. Cancer Res 2015; 75(18): 3728-37.
[http://dx.doi.org/10.1158/0008-5472.CAN-15-0273] [PMID: 26208906]
[11]
Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 2014; 42(Database issue): D92-7.
[http://dx.doi.org/10.1093/nar/gkt1248] [PMID: 24297251]
[12]
Yi Y, Zhao Y, Li C, et al. RAID v2.0: An updated resource of RNA-associated interactions across organisms. Nucleic Acids Res 2017; 45(D1): D115-8.
[http://dx.doi.org/10.1093/nar/gkw1052] [PMID: 27899615]
[13]
Hao Y, Wu W, Li H, et al. NPInter v3.0: An upgraded database of noncoding RNA-associated interactions. J Biol Databases Curat 2016; 2016: baw057.
[14]
Chen G, Wang Z, Wang D, et al. LncRNADisease: A database for long-non-coding RNA-associated diseases. Nucleic Acids Res 2013; 41(Database issue): D983-6.
[PMID: 23175614]
[15]
Ning S, Zhang J, Wang P, et al. Lnc2Cancer: A manually curated database of experimentally supported lncRNAs associated with various human cancers. Nucleic Acids Res 2016; 44(D1): D980-5.
[http://dx.doi.org/10.1093/nar/gkv1094] [PMID: 26481356]
[16]
Futreal PA, Coin L, Marshall M, et al. A census of human cancer genes. Nat Rev Cancer 2004; 4(3): 177-83.
[http://dx.doi.org/10.1038/nrc1299] [PMID: 14993899]
[17]
Mora A, Donaldson IM. iRefR: An R package to manipulate the iRefIndex consolidated protein interaction database. BMC Bioinformatics 2011; 12: 455.
[http://dx.doi.org/10.1186/1471-2105-12-455] [PMID: 22115179]
[18]
Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell 2016; 29(4): 452-63.
[http://dx.doi.org/10.1016/j.ccell.2016.03.010] [PMID: 27070700]
[19]
Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, Qiu F. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosyst 2012; 8(9): 2289-94.
[http://dx.doi.org/10.1039/c2mb25070e] [PMID: 22722759]
[20]
Ji Q, Zhang L, Liu X, et al. Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. Br J Cancer 2014; 111(4): 736-48.
[http://dx.doi.org/10.1038/bjc.2014.383] [PMID: 25025966]
[21]
Xu TP, Huang MD, Xia R, et al. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression. J Hematol Oncol 2014; 7: 63.
[http://dx.doi.org/10.1186/s13045-014-0063-7] [PMID: 25167886]
[22]
Grote P, Wittler L, Hendrix D, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell 2013; 24(2): 206-14.
[http://dx.doi.org/10.1016/j.devcel.2012.12.012] [PMID: 23369715]
[23]
Kuleshov MV, Jones MR, Rouillard AD, et al. Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 2016; 44(W1): W90-7.
[http://dx.doi.org/10.1093/nar/gkw377] [PMID: 27141961]
[24]
Li Y, Qiu C, Tu J, et al. HMDD v2.0: A database for experimentally supported human microRNA and disease associations. Nucleic Acids Res 2014; 42(Database issue): D1070-4.
[http://dx.doi.org/10.1093/nar/gkt1023] [PMID: 24194601]
[25]
Zhang YC, Liao JY, Li ZY, et al. Genome-wide screening and functional analysis identify a large number of long noncoding RNAs involved in the sexual reproduction of rice. Genome Biol 2014; 15(12): 512.
[http://dx.doi.org/10.1186/s13059-014-0512-1] [PMID: 25517485]
[26]
Johnsson P, Lipovich L, Grandér D, Morris KV. Evolutionary conservation of long non-coding RNAs; sequence, structure, function. Biochim Biophys Acta 2014; 1840(3): 1063-71.
[http://dx.doi.org/10.1016/j.bbagen.2013.10.035] [PMID: 24184936]
[27]
Li H, Yu B, Li J, et al. Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget 2014; 5(8): 2318-29.
[http://dx.doi.org/10.18632/oncotarget.1913] [PMID: 24810858]
[28]
Liu Y, Zhao J, Zhang W, et al. lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer. Sci Rep 2015; 5: 10159.
[http://dx.doi.org/10.1038/srep10159] [PMID: 25959498]
[29]
Kim P, Cheng F, Zhao J, Zhao Z. ccmGDB: A database for cancer cell metabolism genes. Nucleic Acids Res 2016; 44(D1): D959-68.
[http://dx.doi.org/10.1093/nar/gkv1128] [PMID: 26519468]
[30]
Hu B, Cai H, Zheng R, Yang S, Zhou Z, Tu J. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression. Int J Biochem Cell Biol 2017; 92: 34-42.
[http://dx.doi.org/10.1016/j.biocel.2017.09.008] [PMID: 28919047]
[31]
Liu H, Li J, Koirala P, et al. Long non-coding RNAs as prognostic markers in human breast cancer. Oncotarget 2016; 7(15): 20584-96.
[http://dx.doi.org/10.18632/oncotarget.7828] [PMID: 26942882]
[32]
Ding X, Zhang Y, Yang H, et al. Long non-coding RNAs may serve as biomarkers in breast cancer combined with primary lung cancer. Oncotarget 2017; 8(35): 58210-21.
[http://dx.doi.org/10.18632/oncotarget.17356] [PMID: 28938549]
[33]
Wang W, Zhao Z, Yang F, et al. An immune-related lncRNA signature for patients with anaplastic gliomas. J Neurooncol 2018; 136(2): 263-71.
[http://dx.doi.org/10.1007/s11060-017-2667-6] [PMID: 29170907]
[34]
Shannon P, Markiel A, Ozier O, et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13(11): 2498-504.
[http://dx.doi.org/10.1101/gr.1239303] [PMID: 14597658]
[35]
Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet 2016; 17(1): 47-62.
[http://dx.doi.org/10.1038/nrg.2015.10] [PMID: 26666209]
[36]
Yang G, Lu X, Yuan L. LncRNA: A link between RNA and cancer. Biochim Biophys Acta 2014; 1839(11): 1097-109.
[http://dx.doi.org/10.1016/j.bbagrm.2014.08.012] [PMID: 25159663]
[37]
Malek E, Jagannathan S, Driscoll JJ. Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer. Oncotarget 2014; 5(18): 8027-38.
[http://dx.doi.org/10.18632/oncotarget.2469] [PMID: 25275300]